In addition to experiencing stigma, discrimination, and a denial of civil and human rights, many members of the LGBTQ community are omitted from clinical trials. And when it comes to testing new drugs, therapies, and devices, there is a huge lack of needed diversity in clinical trials.
Clinical trials are vital in preventing, detecting, and treating disease. Diversity is important in making sure we know all we can about a treatment’s benefits and risks, and the people enrolled in a clinical trial should represent the types of people who are likely to use the therapy.
In this episode, we tackle the topic of increasing inclusivity in research. We're talking to three amazing women from the Accelerated Cure Project for MS. We cover the MS Minority Research Engagement Partnership Network.